tiprankstipranks
Trending News
More News >
Solasto Corp. (JP:6197)
:6197
Japanese Market
Advertisement

Solasto Corp. (6197) AI Stock Analysis

Compare
0 Followers

Top Page

JP:6197

Solasto Corp.

(6197)

Select Model
Select Model
Select Model
Outperform 80 (OpenAI - 4o)
Rating:80Outperform
Price Target:
¥602.00
▲(20.16% Upside)
Solasto Corp. demonstrates strong financial performance and technical indicators, supported by an attractive valuation. The company's consistent revenue growth and strong cash flow generation are key strengths. However, the stock's technical indicators suggest it may be nearing overbought conditions, which could limit short-term upside.
Positive Factors
Revenue Growth
Consistent revenue growth indicates strong demand for Solasto's healthcare services and effective business strategies, supporting long-term expansion.
Cash Flow Generation
Strong cash flow generation enhances financial flexibility, allowing Solasto to invest in growth opportunities and manage debt effectively.
Leverage Management
Improved leverage management reduces financial risk, providing Solasto with a more stable capital structure to support future growth.
Negative Factors
Profitability Margins
Decreasing gross profit margins could pressure Solasto's profitability, potentially limiting reinvestment capacity and affecting long-term financial health.
Equity Ratio
Moderate reliance on debt financing may pose risks if market conditions change, impacting Solasto's ability to manage financial obligations sustainably.
Profitability Improvement
Limited profitability improvement could hinder Solasto's ability to enhance shareholder value and invest in strategic initiatives over the long term.

Solasto Corp. (6197) vs. iShares MSCI Japan ETF (EWJ)

Solasto Corp. Business Overview & Revenue Model

Company DescriptionSolasto Corporation provides medical outsourcing services primarily to medical institutions in Japan. The company's medical outsourcing services include contracted services of medical clerical work. It also offers elderly care services, such as day service, home help, facility-based service, etc.; and childcare services, as well as engages in the education business. The company was formerly known as N.I.C Corporation. Solasto Corporation was founded in 1965 and is headquartered in Tokyo, Japan.
How the Company Makes MoneySolasto Corp. generates revenue through multiple streams, predominantly from its medical facility management services, which include outpatient clinics and rehabilitation centers. The company receives fee-for-service payments from patients and health insurance providers for the medical services rendered. Additionally, Solasto earns income from its nursing care services, which include home care and institutional care for the elderly. Key revenue streams also include partnerships with local governments and healthcare institutions that seek to improve healthcare accessibility and efficiency. The company continuously explores opportunities for expansion and collaboration in the healthcare sector, contributing to its overall financial performance.

Solasto Corp. Financial Statement Overview

Summary
Solasto Corp. exhibits solid financial health with consistent revenue growth and strong cash flow generation. While profitability margins and leverage ratios show room for improvement, the company is on a positive trajectory with effective cash management and improving equity returns.
Income Statement
75
Positive
Solasto Corp. has demonstrated consistent revenue growth, with a notable increase in the TTM period. Gross profit margins have slightly decreased over time, but net profit margins have remained relatively stable. The EBIT and EBITDA margins indicate a healthy operational performance, though there is room for improvement in profitability.
Balance Sheet
70
Positive
The company's debt-to-equity ratio has improved in the TTM period, reflecting better leverage management. Return on equity has shown a positive trend, indicating effective use of equity to generate profits. However, the equity ratio suggests a moderate reliance on debt financing, which could pose risks if not managed carefully.
Cash Flow
80
Positive
Solasto Corp. has shown strong free cash flow growth in the TTM period, recovering from previous declines. The operating cash flow to net income ratio is stable, and the free cash flow to net income ratio is strong, indicating efficient cash generation relative to earnings.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue138.26B137.44B135.14B131.09B117.24B106.18B
Gross Profit21.59B20.75B21.93B21.75B20.46B18.86B
EBITDA10.18B9.85B7.77B8.82B8.47B7.91B
Net Income4.25B3.96B2.26B3.17B3.50B3.54B
Balance Sheet
Total Assets68.27B70.10B75.20B69.85B70.75B60.10B
Cash, Cash Equivalents and Short-Term Investments12.18B14.00B15.12B11.96B10.34B8.97B
Total Debt18.62B23.08B28.52B25.89B28.65B21.75B
Total Liabilities45.36B47.41B54.72B48.28B50.60B41.63B
Stockholders Equity22.91B22.68B20.48B21.57B20.15B18.47B
Cash Flow
Free Cash Flow6.20B5.46B6.28B7.69B4.72B5.78B
Operating Cash Flow6.53B5.88B7.86B9.01B5.52B6.73B
Investing Cash Flow-419.00M347.00M-2.76B-2.17B-7.45B-3.82B
Financing Cash Flow-6.84B-7.33B-1.84B-5.21B3.20B-5.72B

Solasto Corp. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price501.00
Price Trends
50DMA
507.91
Positive
100DMA
476.25
Positive
200DMA
453.02
Positive
Market Momentum
MACD
14.85
Negative
RSI
77.27
Negative
STOCH
86.89
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6197, the sentiment is Positive. The current price of 501 is below the 20-day moving average (MA) of 523.15, below the 50-day MA of 507.91, and above the 200-day MA of 453.02, indicating a bullish trend. The MACD of 14.85 indicates Negative momentum. The RSI at 77.27 is Negative, neither overbought nor oversold. The STOCH value of 86.89 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6197.

Solasto Corp. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
¥53.43B11.864.09%1.86%1370.48%
75
Outperform
¥20.65B11.802.47%3.88%0.31%
72
Outperform
¥35.51B12.122.67%0.30%-31.28%
70
Neutral
¥11.42B21.151.15%18.03%-11.68%
69
Neutral
¥6.84B3.122.71%1.26%562.09%
65
Neutral
¥42.08B11.410.85%15.77%-50.57%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:6197
Solasto Corp.
564.00
119.60
26.91%
JP:2374
Saint-Care Holding Corp.
1,216.00
496.66
69.04%
JP:6059
Uchiyama Holdings Co., Ltd.
382.00
78.34
25.80%
JP:6062
Charm Care Corporation
1,279.00
29.61
2.37%
JP:7061
Japan Hospice Holdings Inc.
1,275.00
-37.59
-2.86%
JP:7071
Amvis Holdings.Inc.
460.00
-400.30
-46.53%

Solasto Corp. Corporate Events

Solasto Corporation Updates on Stock Buy-Back Progress
Oct 1, 2025

Solasto Corporation announced the status of its stock buy-back program, which was initially declared on August 12, 2025. As of September 30, 2025, the company repurchased 259,900 shares of common stock for a total of 126,486,693 yen through market purchases on the Tokyo Stock Exchange. This buy-back is part of a larger plan authorized by the Board of Directors to repurchase up to 4,400,000 shares, with an aggregate repurchase amount of up to 1.4 billion yen, to be executed by May 31, 2026. The buy-back initiative aims to enhance shareholder value and optimize the company’s capital structure.

The most recent analyst rating on (JP:6197) stock is a Buy with a Yen540.00 price target. To see the full list of analyst forecasts on Solasto Corp. stock, see the JP:6197 Stock Forecast page.

Solasto Corp. Announces Change in Corporate Directorate
Oct 1, 2025

Solasto Corporation has announced a change in its corporate directorate, effective October 1, 2025. Kazuhiro Mashihara will take on new responsibilities as the Chief Information Officer and General Manager of IT Strategy Division, while also being in charge of Business Development. This change reflects the company’s strategic focus on strengthening its IT and business development capabilities, potentially impacting its market positioning and operational effectiveness.

The most recent analyst rating on (JP:6197) stock is a Buy with a Yen540.00 price target. To see the full list of analyst forecasts on Solasto Corp. stock, see the JP:6197 Stock Forecast page.

Solasto Corporation Announces Strategic Stock Buy-back Plan
Aug 12, 2025

Solasto Corporation announced a stock buy-back plan as part of its Medium-term Business Plan for FY2025–2029, aiming to improve capital efficiency and enhance shareholder returns. The company plans to repurchase up to 4.8% of its outstanding common stock, with a total aggregate repurchase amount of up to 1.4 billion yen, through market purchases on the Tokyo Stock Exchange between August 13, 2025, and May 31, 2026.

The most recent analyst rating on (JP:6197) stock is a Hold with a Yen550.00 price target. To see the full list of analyst forecasts on Solasto Corp. stock, see the JP:6197 Stock Forecast page.

Solasto Corporation Reports Q1 FY2025 Financial Results with Increased Net Income
Aug 12, 2025

Solasto Corporation reported its Q1 FY2025 financial results, showing a slight increase in net sales by 2.4% compared to the previous year, reaching 34,926 million yen. Despite a decline in operating profit by 4.1%, the company experienced a significant increase in net income by 34.5%. The company maintained its dividend forecast for FY2025, with a slight increase expected in the year-end dividend per share. The financial results indicate a stable market position, although there are challenges in maintaining operating profit levels.

The most recent analyst rating on (JP:6197) stock is a Hold with a Yen550.00 price target. To see the full list of analyst forecasts on Solasto Corp. stock, see the JP:6197 Stock Forecast page.

Solasto Completes Treasury Stock Disposal for Compensation
Aug 7, 2025

Solasto Corporation, a company listed on the Tokyo Stock Exchange, has completed the payment process for the disposal of treasury stock as restricted stock compensation. This move involves the disposal of 72,756 shares of common stock at a price of 417 yen per share, amounting to a total of 30,339,252 yen. The shares are allocated to two directors and two corporate officers, marking a strategic step in aligning the interests of key personnel with the company’s performance.

The most recent analyst rating on (JP:6197) stock is a Hold with a Yen550.00 price target. To see the full list of analyst forecasts on Solasto Corp. stock, see the JP:6197 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 24, 2025